• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在直接经皮冠状动脉血管成形术后,以心肌梗死溶栓治疗(TIMI)血流分级来识别延迟血流和无复流的预测因素。

Predictors of delayed and no-reflow as recognized with Thrombolysis in Myocardial Infarction [TIMI] flow grade following Primary Percutaneous Coronary Angioplasty.

作者信息

Bahrehmand M, Sadeghi E, Shafiee A, Nozari Y

机构信息

Department of Cardiology, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Department of Surgery, Kermanshah University of Medical Sciences, Kermanshah, Iran.

出版信息

J Med Life. 2015;8(Spec Iss 3):59-65.

PMID:28316667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5348964/
Abstract

Initial percutaneous coronary interference (PCI) is still connected by a noticeable incidence of suboptimal coronary flow thrombolysis in infarction of myocardial (TIMI). The predictors of slow and no-reflow in cases that supported initial PCI in our institute was searched for and the relationship of these parameters with major adverse cardiovascular effects (MACE) was assessed. 397 patients with AMI displaying in 24 hours of the sign opening were retrospectively enrolled and underwent primary PCI between March 2006 and March 2012. Demographic, clinical, and procedural data were retrieved from our institutional databank. The baseline and post-PCI flow of blood in the revascularized artery was ranked based on the TIMI grading method. The follow-up visits were performed after one, six and twelve month from hospitalization. All the mortalities and complications were recorded within this period for evaluate the MACE. The frequency of diabetes mellitus and renal failure were importantly larger in cases with a TIMI flow of 0-1 (p=0.03 & p=.01, respectively). Similarly, level of serum creatine were importantly larger in cases with a TIMI flow of 0-1. The predictors for TIMI flow included that utilize of Adenosin or Integrilin, diabetes mellitus, POIT, long tubular lesion, and injury at LAD territory. The incidence of MACE was significantly higher in patients with a TIMI flow of 0-1 (P=0.001) and the survival in this subgroup was significantly poorer (Hazard ratio=4.96; P<0.001). A low TIMI flow is accompanied by a poorer survival and a higher MACE and is influenced by some clinical and vascular characteristics.

摘要

初始经皮冠状动脉介入治疗(PCI)后仍有相当比例的患者出现心肌梗死溶栓治疗心肌梗死分级(TIMI)血流未达最佳状态。本研究旨在寻找我院支持初始PCI治疗患者中慢血流和无复流的预测因素,并评估这些参数与主要不良心血管事件(MACE)的关系。回顾性纳入2006年3月至212012年3月期间397例发病24小时内就诊并接受直接PCI的急性心肌梗死(AMI)患者。从我院数据库中获取人口统计学、临床和手术数据。根据TIMI分级方法对血管重建术后动脉的基线和PCI后血流进行分级。住院后1个月、6个月和12个月进行随访。记录该期间内所有死亡和并发症情况以评估MACE。TIMI血流为0 - 1级的患者中糖尿病和肾衰竭的发生率显著更高(分别为p = 0.03和p = 0.01)。同样,TIMI血流为0 - 1级的患者血清肌酐水平也显著更高。TIMI血流的预测因素包括使用腺苷或依替巴肽、糖尿病、POIT、长管状病变以及左前降支区域损伤。TIMI血流为0 - 1级的患者MACE发生率显著更高(P = 0.001),该亚组患者的生存率显著更低(风险比=4.96;P < 0.001)。低TIMI血流与较差的生存率和较高的MACE相关,并受一些临床和血管特征的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c42f/5348964/b18dde480065/SIJMedLife-08-03-59-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c42f/5348964/b18dde480065/SIJMedLife-08-03-59-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c42f/5348964/b18dde480065/SIJMedLife-08-03-59-g001.jpg

相似文献

1
Predictors of delayed and no-reflow as recognized with Thrombolysis in Myocardial Infarction [TIMI] flow grade following Primary Percutaneous Coronary Angioplasty.在直接经皮冠状动脉血管成形术后,以心肌梗死溶栓治疗(TIMI)血流分级来识别延迟血流和无复流的预测因素。
J Med Life. 2015;8(Spec Iss 3):59-65.
2
Predictors and implications of coronary infarct artery patency at initial angiography in patients with acute myocardial infarction (from the CADILLAC and HORIZONS-AMI Trials).急性心肌梗死患者初始血管造影时冠状动脉梗死动脉再通的预测因素及其意义(来自 CADILLAC 和 HORIZONS-AMI 试验)。
Am J Cardiol. 2011 Oct 1;108(7):918-23. doi: 10.1016/j.amjcard.2011.05.022. Epub 2011 Jul 20.
3
Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.尼可地尔预防直接经皮冠状动脉介入治疗中的无复流/慢复流现象
Indian Heart J. 2007 May-Jun;59(3):246-9.
4
Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.入院时红细胞分布宽度-血小板比值对接受直接经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者无复流现象的预测价值
Cardiol J. 2016;23(1):84-92. doi: 10.5603/CJ.a2015.0070. Epub 2015 Oct 27.
5
Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.急性心肌梗死患者经皮冠状动脉介入治疗后冠脉内注射山莨菪碱对慢血流现象的影响
Chin Med J (Engl). 2007 Jul 20;120(14):1226-31.
6
Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.替罗非班辅助治疗对接受直接经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者的临床益处。
Coron Artery Dis. 2008 Jun;19(4):271-7. doi: 10.1097/MCA.0b013e3282f487e0.
7
[Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention].[ST段抬高型心肌梗死患者行直接冠状动脉介入治疗时血清尿酸水平与冠状动脉血流的相关性]
Zhonghua Yi Xue Za Zhi. 2012 Nov 27;92(44):3100-3.
8
[Post primary percutaneous coronary intervention no-reflow in patients with acute myocardial infarction: contributing factors and long-term prognostic impact].[急性心肌梗死患者直接经皮冠状动脉介入治疗后无复流:相关因素及长期预后影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Jun;34(6):483-6.
9
Early administration of intracoronary verapamil improves myocardial perfusion during percutaneous coronary interventions for acute myocardial infarction.急性心肌梗死经皮冠状动脉介入治疗期间早期冠状动脉内给予维拉帕米可改善心肌灌注。
Chest. 2005 Oct;128(4):2593-8. doi: 10.1378/chest.128.4.2593.
10
Effect of reactive hyperemia after coronary recanalization on myocardial tissue reperfusion by thrombolysis in myocardial infarction flow grade in acute myocardial infarction.急性心肌梗死中冠状动脉再通后反应性充血对心肌组织再灌注及心肌梗死溶栓血流分级的影响。
Am J Cardiol. 2006 Mar 1;97(5):617-23. doi: 10.1016/j.amjcard.2005.09.100. Epub 2006 Jan 6.

引用本文的文献

1
Adenosine as an Adjunctive Therapy for Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.腺苷作为接受直接经皮冠状动脉介入治疗的急性心肌梗死的辅助治疗:一项随机对照试验的系统评价和荟萃分析
Rev Cardiovasc Med. 2025 Feb 12;26(2):24065. doi: 10.31083/RCM24065. eCollection 2025 Feb.
2
Impact of multimorbidity on risk stratification and prognosis in elderly patients after acute myocardial infarction.多种疾病共存对老年急性心肌梗死后患者风险分层及预后的影响。
J Thorac Dis. 2024 Oct 31;16(10):6677-6687. doi: 10.21037/jtd-24-772. Epub 2024 Oct 30.
3

本文引用的文献

1
Percutaneous coronary intervention to treat chronic total occlusion: predictors of technical success and one-year clinical outcome.经皮冠状动脉介入治疗慢性完全闭塞病变:技术成功的预测因素及一年临床结局
Tex Heart Inst J. 2014 Feb;41(1):40-7. doi: 10.14503/THIJ-12-2731.
2
Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction?经皮冠状动脉介入术前给予高负荷剂量阿托伐他汀能否降低围手术期心肌梗死?
Curr Med Res Opin. 2014 Mar;30(3):381-6. doi: 10.1185/03007995.2013.834249. Epub 2013 Nov 7.
3
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.
Clinical, Laboratory, and Procedural Predictors of No-Reflow in Patients Undergoing Primary Percutaneous Coronary Intervention.
接受直接经皮冠状动脉介入治疗患者无复流现象的临床、实验室及操作预测因素
J Tehran Heart Cent. 2020 Apr;15(2):50-56. doi: 10.18502/jthc.v15i2.4183.
急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗时冠状动脉内与静脉内推注阿昔单抗的比较:AIDA STEMI 试验的心脏磁共振子研究。
J Am Coll Cardiol. 2013 Apr 2;61(13):1447-54. doi: 10.1016/j.jacc.2013.01.048. Epub 2013 Feb 27.
4
One-year clinical outcomes of ultra long apollo polymer-based Paclitaxel-eluting stents in patients with complex, long coronary artery lesions.超长效阿波罗聚合物涂层紫杉醇洗脱支架治疗复杂长冠状动脉病变患者的一年临床结局
J Tehran Heart Cent. 2011 Summer;6(3):138-42. Epub 2011 Aug 31.
5
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.尽管在急性心肌梗死中成功进行了机械干预,但导丝插入后持续无复流是一个早期且易于获得的死亡风险因素:来自 STRATEGY(单次大剂量替罗非班和西罗莫司洗脱支架与阿昔单抗和裸金属支架治疗急性心肌梗死)和 MULTISTRATEGY(多中心评估单次大剂量替罗非班与阿昔单抗与西罗莫司洗脱支架或裸金属支架治疗急性心肌梗死的研究)试验的汇总分析。
JACC Cardiovasc Interv. 2011 Jan;4(1):51-62. doi: 10.1016/j.jcin.2010.09.016.
6
Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction.ST 段抬高型急性心肌梗死患者行急诊经皮冠状动脉介入治疗时发生血管造影慢血流/无复流现象的预测因素及长期预后。
Clin Cardiol. 2010 Dec;33(12):E7-12. doi: 10.1002/clc.20634.
7
Usefulness of intraplatelet melatonin levels to predict angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.血小板内褪黑素水平对 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后无复流的预测价值。
Am J Cardiol. 2010 Dec 1;106(11):1540-4. doi: 10.1016/j.amjcard.2010.07.030. Epub 2010 Oct 14.
8
Prediction of the no-reflow phenomenon during percutaneous coronary intervention using coronary computed tomography angiography.使用冠状动脉计算机断层扫描血管造影术预测经皮冠状动脉介入治疗期间的无复流现象。
Heart Vessels. 2011 Jul;26(4):363-9. doi: 10.1007/s00380-010-0059-3. Epub 2010 Nov 6.
9
No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy.经皮冠状动脉介入治疗急性心肌梗死后无复流现象:发生率、结局和药物治疗的影响。
J Interv Cardiol. 2010 Oct;23(5):429-36. doi: 10.1111/j.1540-8183.2010.00561.x. Epub 2010 Aug 31.
10
5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction.急性心肌梗死后经皮冠状动脉介入治疗无复流现象的 5 年预后价值。
J Am Coll Cardiol. 2010 May 25;55(21):2383-9. doi: 10.1016/j.jacc.2009.12.054.